Pharmaceutical

Moderna pauses plans to build mRNA facility in Kenya

Moderna has announced the halt of its project to build a messenger ribonucleic acid (mRNA) manufacturing facility in Kenya.

Apr 13, 2024 - 00:00
Moderna pauses plans to build mRNA facility in Kenya
Moderna has announced the halt of its project to build a messenger ribonucleic acid (mRNA) manufacturing facility in Kenya.
Read the original article

Tags:

Previous Article

Century secures $60m in stock sale and buys preclinical cell therapy biotech

Next Article

Fujifilm invests $1.2bn ramping up North Carolina facility

What's Your Reaction?

like

dislike

love

funny

angry

sad

wow

Related Posts

STAT+: As demand for Covid shots wanes, Moderna seeks its next success

STAT+: As demand for Covid shots wanes, Moderna seeks i...

Jun 26, 2023

Cold chain storage and distribution for the pharmaceutical industry

Cold chain storage and distribution for the pharmaceuti...

May 21, 2024

STAT+: Do GLP-1s have a future treating alcoholism?

STAT+: Do GLP-1s have a future treating alcoholism?

Dec 3, 2023